<SEC-DOCUMENT>0001193125-24-079759-index.html : 20240328 <SEC-HEADER>0001193125-24-079759.hdr.sgml : 20240328 <ACCEPTANCE-DATETIME>20240328081608 ACCESSION NUMBER: 0001193125-24-079759 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 EFFECTIVENESS DATE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Candel Therapeutics, Inc. CENTRAL INDEX KEY: 0001841387 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 522214851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-278294 FILM NUMBER: 24793642 BUSINESS ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 450 CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 617-916-5445 MAIL ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 450 CITY: NEEDHAM STATE: MA ZIP: 02494 FORMER COMPANY: FORMER CONFORMED NAME: Candel Therapeutics, Inic. DATE OF NAME CHANGE: 20210120 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>d813440ds8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: d813440ds8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d813440dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d813440dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>d813440dex231.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: d813440dex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>d813440dexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: d813440dexfilingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g813440dsp2.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g813440dsp2.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g813440g0327073336011.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g813440g0327073336011.jpg
</DOCUMENT> </SEC-DOCUMENT>